白帆生物 白帆生物
白帆生物

同城快餐500喝茶

DRAGON SAIL PHARMACEUTICAL

Provide One-stop full cycle antibody drugs

CDMO/CMO Innovative solutions

Focus on antibody drugs

Contract development and Production service (CDMO)

Dragon Sail Pharmaceutical Co., Ltd. is a high-tech enterprise focusing on antibody drug CDMO services, and it is dedicated to providing one-stop services for partners from sequence to IND, clinical sample production to BLA and commercial production of antibody drugs. Dragon Sail Pharmaceutical has built the first cross-free antibody plant in China in Lin-gang Special Area of China (Shanghai) Pilot Free Trade Zone, with a total investment of nearly RMB 700 million and a production scale of up to 12,000L. The site complies with Chinese, American and European GMP standards, and its unique NONCROS® cross-free antibody production platform complies with requirements for co-linear production of multiple products, featuring high overall operational efficiency and cost-effectiveness. Leveraging its integrated biopharmaceutical technology platform, Dragon Sail will accelerate the process of discovery, development and production of biological drugs especially for antibody drugs, empowering partners and benefiting patients.
  • 2016 Year
    Founded
  • 6.9 hundred million
    Total investment
  • 6*2000 L
    Max Production Scale

Empowering partners to innovate, reduce costs and optimize efficiency

  • Its business services focus on preclinical pharmacological study, clinical drug manufacturing, regulatory affairs and commercial production of a wide range of biologic drugs, including monoclonal antibodies, bispecific antibodies, fusion proteins and peptides.

  • Dragon Sail Pharmaceutical continues to provide a full range of CDMO services to biopharmaceutical companies in the industry, empowering partners to work towards a healthy future based on its excellent process development and high quality product delivery capabilities.

News

  • Dragon Sail Pharmaceutical promotes Vivavision Bio in opphthalmology innovative drug development

  • Cooperation · Empowerment | Dragon Sail Pharmaceutical promotes Vivavision Bio in opphthalmology innovative drug development

  • Dragon Sail Pharmaceutical was selected as the public list of smart factory enterprises in Lin-gang Special Area of China (Shanghai) Pilot Free Trade Zone in 2022

DRAGON SAIL PHARMACEUTICAL

Provide One-stop full cycle antibody drugs

CDMO/CMO Innovative solutions

Focus on antibody drugs

Contract development and Production service (CDMO)

Dragon Sail Pharmaceutical Co., Ltd. is a high-tech enterprise focusing on antibody drug CDMO services, and it is dedicated to providing one-stop services for partners from sequence to IND, clinical sample production to BLA and commercial production of antibody drugs. Dragon Sail Pharmaceutical has built the first cross-free antibody plant in China in Lin-gang Special Area of China (Shanghai) Pilot Free Trade Zone, with a total investment of nearly RMB 700 million and a production scale of up to 12,000L. The site complies with Chinese, American and European GMP standards, and its unique NONCROS® cross-free antibody production platform complies with requirements for co-linear production of multiple products, featuring high overall operational efficiency and cost-effectiveness. Leveraging its integrated biopharmaceutical technology platform, Dragon Sail will accelerate the process of discovery, development and production of biological drugs especially for antibody drugs, empowering partners and benefiting patients.
  • 2016 Year
    Founded
  • 6.9 Hundred million
    Total investment
  • 6*1200 L
    Max Production Scale

Empowering partners to innovate, reduce costs and optimize efficiency

Its business services focus on preclinical pharmacological study, clinical drug manufacturing, regulatory affairs and commercial production of a wide range of biologic drugs, including monoclonal antibodies, bispecific antibodies, fusion proteins and peptides.

Dragon Sail Pharmaceutical continues to provide a full range of CDMO services to biopharmaceutical companies in the industry, empowering partners to work towards a healthy future based on its excellent process development and high quality product delivery capabilities.

News

More

  • Dragon Sail Pharmaceutical promotes Vivavision Bio in opphthalmology innovative drug development111

  • Cooperation · Empowerment | Dragon Sail Pharmaceutical promotes Vivavision Bio in opphthalmology innovative drug development111

  • Dragon Sail Pharmaceutical was selected as the public list of smart factory enterprises in Lin-gang Special Area of China (Shanghai) Pilot Free Trade Zone in 2022111